Cincera Therapeutics Overview
- Founded
- 2018

- Status
- Private
- Employees
- 6

- Latest Deal Type
- Grant
- Latest Deal Amount
- $1M

- Investors
- 3
Cincera Therapeutics General Information
Description
Developer of inflammatory and fibrotic illness drug designed to cure metabolic diseases. The company's drug treats difficult-to-treat inflammatory and fibrotic conditions associated with obesity and also has applicability in many other disease areas including cancer, and liver problems, enabling doctors to cure patients effectively.
Contact Information
Website
www.cinceratx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Cincera Therapeutics Timeline
Cincera Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Grant | 03-Sep-2020 | $1M | 00.000 | Completed | Generating Revenue | |
1. Early Stage VC | 19-Feb-2018 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
Cincera Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Preference | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Cincera Therapeutics Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Bernard Flynn | Co-Founder, Chief Executive Officer & Research Director | ||
Stuart Pitson | Co-Founder & Chief Scientific Officer | ||
Roberto Solari Ph.D | Advisor |
Cincera Therapeutics Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Ben Atcliffe Ph.D | Cincera Therapeutics | Board Observer | 000 0000 |
Katherine Nielsen | Cincera Therapeutics | Board Member | 000 0000 |
Melissa McBurnie Ph.D | Brandon Capital | Board Member | 000 0000 |
Michael Bettess Ph.D | Brandon Capital | Chairman | 000 0000 |
Cincera Therapeutics Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCincera Therapeutics Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Australian Government's Department of Health | Government | 000 0000 | 000000 0 | ||
AustralianSuper | Limited Partner | Minority | 000 0000 | 000000 0 | |
Brandon Capital | Venture Capital | Minority | 000 0000 | 000000 0 |